Literature DB >> 15767351

Similar uptake of lung carcinogens by smokers of regular, light, and ultralight cigarettes.

Stephen S Hecht1, Sharon E Murphy, Steven G Carmella, Shelby Li, Joni Jensen, Chap Le, Anne M Joseph, Dorothy K Hatsukami.   

Abstract

Cigarette design has changed markedly over the past 60 years and sales-weighed levels of tar and nicotine have decreased. Currently, cigarettes are classified as regular (>14.5 mg tar), light (>6.5-14.5 mg tar), and ultralight (< or =6.5 mg tar), based on a Federal Trade Commission-specified machine-smoking protocol. Epidemiologic studies suggest that there is no difference in lung cancer risk among people who smoke light or ultralight cigarettes compared with regular cigarettes, but the uptake of lung carcinogens in smokers of these types of cigarettes has never been reported. We recruited 175 smokers, who filled out a tobacco use questionnaire in which their current brand was identified as regular, light, or ultralight. Urine samples were collected and analyzed for 1-hydroxypyrene (1-HOP), total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL plus its glucuronides) and total cotinine (cotinine plus its glucuronides). 1-HOP and total NNAL are biomarkers of uptake of polycyclic aromatic hydrocarbons and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, lung carcinogens in cigarette smoke. Total cotinine is a biomarker of nicotine uptake. There were no statistically significant differences in urinary levels of 1-HOP, total NNAL, and total cotinine in smokers of regular, light, and ultralight cigarettes, whether the results were expressed per mg urinary creatinine, per mL of urine, or per mg creatinine divided by cigarettes per day. Levels of machine measured tar were available for the cigarettes smoked by 149 of the subjects. There was no correlation between levels of tar and any of the biomarkers. These results indicate that lung carcinogen and nicotine uptake, as measured by urinary 1-HOP, total NNAL, and total cotinine is the same in smokers of regular, light, and ultralight cigarettes. The results are consistent with epidemiologic studies that show no difference in lung cancer risk in smokers of these cigarettes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15767351     DOI: 10.1158/1055-9965.EPI-04-0542

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  47 in total

1.  Do smokers in Europe think all cigarettes are equally harmful?

Authors:  Abraham Brown; Ann McNeill; Ute Mons; Romain Guignard
Journal:  Eur J Public Health       Date:  2012-02       Impact factor: 3.367

2.  Smoking, smoking cessation, and risk of cardiovascular disease.

Authors:  Peter W F Wilson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-08

3.  Smokeless tobacco brand switching: a means to reduce toxicant exposure?

Authors:  D K Hatsukami; J O Ebbert; A Anderson; H Lin; C Le; S S Hecht
Journal:  Drug Alcohol Depend       Date:  2006-09-20       Impact factor: 4.492

4.  Cigarette rod length and its impact on serum cotinine and urinary total NNAL levels, NHANES 2007-2010.

Authors:  Israel T Agaku; Constantine I Vardavas; Gregory N Connolly
Journal:  Nicotine Tob Res       Date:  2013-09-21       Impact factor: 4.244

5.  Transdisciplinary Tobacco Use Research Centers: research achievements and future implications.

Authors:  Timothy B Baker; K Michael Cummings; Dorothy K Hatsukami; C Anderson Johnson; Caryn Lerman; Raymond Niaura; Stephanie S O'Malley
Journal:  Nicotine Tob Res       Date:  2009-07-24       Impact factor: 4.244

Review 6.  Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco.

Authors:  Michael D Johnson; Jodi Schilz; Mirjana V Djordjevic; Jerry R Rice; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

Review 7.  Dependence of tar, nicotine and carbon monoxide yields on physical parameters: implications for exposure, emissions control and monitoring.

Authors:  W E Stephens
Journal:  Tob Control       Date:  2007-06       Impact factor: 7.552

Review 8.  Reconciling human smoking behavior and machine smoking patterns: implications for understanding smoking behavior and the impact on laboratory studies.

Authors:  Catalin Marian; Richard J O'Connor; Mirjana V Djordjevic; Vaughan W Rees; Dorothy K Hatsukami; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

Review 9.  Cigarette filter-based assays as proxies for toxicant exposure and smoking behavior--a literature review.

Authors:  John L Pauly; Richard J O'Connor; Geraldine M Paszkiewicz; K Michael Cummings; Mirjana V Djordjevic; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

Review 10.  Clinical trials methods for evaluation of potential reduced exposure products.

Authors:  Dorothy K Hatsukami; Karen Hanson; Anna Briggs; Mark Parascandola; Jeanine M Genkinger; Richard O'Connor; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.